位置:首页 > 蛋白库 > DHX33_HUMAN
DHX33_HUMAN
ID   DHX33_HUMAN             Reviewed;         707 AA.
AC   Q9H6R0; B4DHF9; Q4G149; Q5CZ73; Q9H5M9;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=ATP-dependent RNA helicase DHX33 {ECO:0000305};
DE            EC=3.6.4.13;
DE   AltName: Full=DEAH box protein 33;
GN   Name=DHX33 {ECO:0000312|HGNC:HGNC:16718}; Synonyms=DDX33;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 119-128; 130-138 AND 200-211, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 293-707.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   FUNCTION, ASSOCIATION WITH RIBOSOMAL DNA LOCI, INTERACTION WITH UBTF, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=21930779; DOI=10.1128/mcb.05832-11;
RA   Zhang Y., Forys J.T., Miceli A.P., Gwinn A.S., Weber J.D.;
RT   "Identification of DHX33 as a mediator of rRNA synthesis and cell growth.";
RL   Mol. Cell. Biol. 31:4676-4691(2011).
RN   [8]
RP   FUNCTION, DOUBLE-STRANDED RNA-BINDING, MUTAGENESIS OF LYS-103, INTERACTION
RP   WITH NLRP3, AND SUBCELLULAR LOCATION.
RX   PubMed=23871209; DOI=10.1016/j.immuni.2013.07.001;
RA   Mitoma H., Hanabuchi S., Kim T., Bao M., Zhang Z., Sugimoto N., Liu Y.J.;
RT   "The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3
RT   inflammasome.";
RL   Immunity 39:123-135(2013).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DDX3X; EIF3G; EIF3H; RPL3;
RP   RPL7; RPL26 AND RPL27, AND RNA-BINDING.
RX   PubMed=26100019; DOI=10.1128/mcb.00315-15;
RA   Zhang Y., You J., Wang X., Weber J.;
RT   "The DHX33 RNA Helicase Promotes mRNA Translation Initiation.";
RL   Mol. Cell. Biol. 35:2918-2931(2015).
CC   -!- FUNCTION: Implicated in nucleolar organization, ribosome biogenesis,
CC       protein synthesis and cytoplasmic dsRNA sensing (By similarity)
CC       (PubMed:21930779, PubMed:23871209, PubMed:26100019). Stimulates RNA
CC       polymerase I transcription of the 47S precursor rRNA. Associates with
CC       ribosomal DNA (rDNA) loci where it is involved in POLR1A recruitment
CC       (PubMed:21930779). In the cytoplasm, promotes elongation-competent 80S
CC       ribosome assembly at the late stage of mRNA translation initiation
CC       (PubMed:26100019). Senses cytosolic dsRNA mediating NLRP3 inflammasome
CC       formation in macrophages and type I interferon production in myeloid
CC       dendritic cells (PubMed:23871209). Required for NLRP3 activation
CC       induced by viral dsRNA and bacterial RNA (PubMed:23871209). In
CC       dendritic cells, required for induction of type I interferon production
CC       induced by cytoplasmic dsRNA via the activation of MAPK and NF-kappa-B
CC       signaling pathways (By similarity). {ECO:0000250|UniProtKB:Q80VY9,
CC       ECO:0000269|PubMed:21930779, ECO:0000269|PubMed:23871209,
CC       ECO:0000269|PubMed:26100019}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- SUBUNIT: Interacts with UBTF (PubMed:21930779). Interacts with DDX3X,
CC       EIF3G and EIF3H; the interaction is independent of RNA
CC       (PubMed:26100019). Interacts (via HA2 region and Helicase C-terminal
CC       domain) with the components of the large ribosomal subunit RPL3, RPL7,
CC       RPL26 and RPL27 (PubMed:26100019). Interacts (via DEAH box) with NLRP3
CC       (via NACHT domain) (PubMed:23871209). Binds to mRNA (PubMed:26100019).
CC       Binds to double-stranded RNA (via the helicase C-terminal domain)
CC       (PubMed:23871209). Interacts (via the helicase C-terminal domain) with
CC       MAVS (By similarity). {ECO:0000250|UniProtKB:Q80VY9,
CC       ECO:0000269|PubMed:21930779, ECO:0000269|PubMed:23871209,
CC       ECO:0000269|PubMed:26100019}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21930779,
CC       ECO:0000269|PubMed:26100019}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:21930779}. Cytoplasm {ECO:0000269|PubMed:23871209,
CC       ECO:0000269|PubMed:26100019}. Nucleus {ECO:0000269|PubMed:23871209}.
CC       Inflammasome {ECO:0000269|PubMed:23871209}. Note=Predominantly in the
CC       nucleolus. During mitosis, localizes with the nucleolar organizing
CC       regions (PubMed:21930779). Upon dsRNA-binding, localizes in the
CC       inflammasome (PubMed:23871209). {ECO:0000269|PubMed:21930779,
CC       ECO:0000269|PubMed:23871209}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H6R0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H6R0-2; Sequence=VSP_016256;
CC   -!- PTM: Ubiquitinated, leading to its degradation by the proteasome.
CC       Deubiquitinated by USP36. {ECO:0000250|UniProtKB:Q80VY9}.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DEAH subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH30017.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK025625; BAB15193.1; -; mRNA.
DR   EMBL; AK026944; BAB15596.1; -; mRNA.
DR   EMBL; AK295074; BAG58120.1; -; mRNA.
DR   EMBL; AC004148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90332.1; -; Genomic_DNA.
DR   EMBL; BC030017; AAH30017.1; ALT_INIT; mRNA.
DR   EMBL; CR936655; CAI56793.1; -; mRNA.
DR   CCDS; CCDS11072.1; -. [Q9H6R0-1]
DR   RefSeq; NP_001186628.1; NM_001199699.1. [Q9H6R0-2]
DR   RefSeq; NP_064547.2; NM_020162.3. [Q9H6R0-1]
DR   RefSeq; XP_016880366.1; XM_017024877.1.
DR   AlphaFoldDB; Q9H6R0; -.
DR   SMR; Q9H6R0; -.
DR   BioGRID; 121247; 69.
DR   IntAct; Q9H6R0; 22.
DR   MINT; Q9H6R0; -.
DR   STRING; 9606.ENSP00000225296; -.
DR   iPTMnet; Q9H6R0; -.
DR   PhosphoSitePlus; Q9H6R0; -.
DR   BioMuta; DHX33; -.
DR   DMDM; 296434478; -.
DR   EPD; Q9H6R0; -.
DR   jPOST; Q9H6R0; -.
DR   MassIVE; Q9H6R0; -.
DR   MaxQB; Q9H6R0; -.
DR   PaxDb; Q9H6R0; -.
DR   PeptideAtlas; Q9H6R0; -.
DR   PRIDE; Q9H6R0; -.
DR   ProteomicsDB; 81012; -. [Q9H6R0-1]
DR   ProteomicsDB; 81013; -. [Q9H6R0-2]
DR   Antibodypedia; 23699; 81 antibodies from 11 providers.
DR   DNASU; 56919; -.
DR   Ensembl; ENST00000225296.8; ENSP00000225296.3; ENSG00000005100.13. [Q9H6R0-1]
DR   GeneID; 56919; -.
DR   KEGG; hsa:56919; -.
DR   MANE-Select; ENST00000225296.8; ENSP00000225296.3; NM_020162.4; NP_064547.2.
DR   UCSC; uc002gca.3; human. [Q9H6R0-1]
DR   CTD; 56919; -.
DR   DisGeNET; 56919; -.
DR   GeneCards; DHX33; -.
DR   HGNC; HGNC:16718; DHX33.
DR   HPA; ENSG00000005100; Low tissue specificity.
DR   MIM; 614405; gene.
DR   neXtProt; NX_Q9H6R0; -.
DR   OpenTargets; ENSG00000005100; -.
DR   PharmGKB; PA27220; -.
DR   VEuPathDB; HostDB:ENSG00000005100; -.
DR   eggNOG; KOG0922; Eukaryota.
DR   GeneTree; ENSGT00940000156747; -.
DR   HOGENOM; CLU_001832_5_11_1; -.
DR   InParanoid; Q9H6R0; -.
DR   OMA; HIHRTTP; -.
DR   PhylomeDB; Q9H6R0; -.
DR   TreeFam; TF354245; -.
DR   PathwayCommons; Q9H6R0; -.
DR   SignaLink; Q9H6R0; -.
DR   BioGRID-ORCS; 56919; 602 hits in 1080 CRISPR screens.
DR   ChiTaRS; DHX33; human.
DR   GenomeRNAi; 56919; -.
DR   Pharos; Q9H6R0; Tbio.
DR   PRO; PR:Q9H6R0; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9H6R0; protein.
DR   Bgee; ENSG00000005100; Expressed in secondary oocyte and 185 other tissues.
DR   ExpressionAtlas; Q9H6R0; baseline and differential.
DR   Genevisible; Q9H6R0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0072559; C:NLRP3 inflammasome complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IEA:Ensembl.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0000182; F:rDNA binding; IDA:UniProtKB.
DR   GO; GO:0043023; F:ribosomal large subunit binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:UniProtKB-EC.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:1900227; P:positive regulation of NLRP3 inflammasome complex assembly; IDA:UniProtKB.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IDA:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISS:UniProtKB.
DR   GO; GO:0006413; P:translational initiation; IEA:Ensembl.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR011709; DEAD-box_helicase_OB_fold.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR002464; DNA/RNA_helicase_DEAH_CS.
DR   InterPro; IPR007502; Helicase-assoc_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF04408; HA2; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF07717; OB_NTP_bind; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00847; HA2; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00690; DEAH_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Direct protein sequencing;
KW   Helicase; Hydrolase; Inflammasome; Nucleotide-binding; Nucleus;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..707
FT                   /note="ATP-dependent RNA helicase DHX33"
FT                   /id="PRO_0000055164"
FT   DOMAIN          84..252
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          277..450
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..80
FT                   /note="Required for nucleolar location"
FT                   /evidence="ECO:0000269|PubMed:26100019"
FT   REGION          1..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          471..562
FT                   /note="HA2; required for interaction with EIF3G and RPL26"
FT                   /evidence="ECO:0000269|PubMed:26100019"
FT   MOTIF           194..197
FT                   /note="DEAH box"
FT   MOTIF           547..558
FT                   /note="Critical for rDNA-binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         97..104
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   VAR_SEQ         1..173
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016256"
FT   VARIANT         118
FT                   /note="R -> C (in dbSNP:rs8069315)"
FT                   /id="VAR_057239"
FT   VARIANT         483
FT                   /note="H -> D (in dbSNP:rs11653658)"
FT                   /id="VAR_057240"
FT   MUTAGEN         103
FT                   /note="K->N: No effect on inflammasome activation upon
FT                   dsRNA-binding."
FT                   /evidence="ECO:0000269|PubMed:23871209"
FT   CONFLICT        77
FT                   /note="F -> L (in Ref. 1; BAB15193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        166
FT                   /note="R -> G (in Ref. 1; BAB15193)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        377
FT                   /note="A -> V (in Ref. 4; AAH30017)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        539
FT                   /note="P -> S (in Ref. 6; CAI56793)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   707 AA;  78874 MW;  E3515B12BD972431 CRC64;
     MPEEAGFPPA KRFRPGSGPP SRAGSFPPGR QVVMLLTAGS GGRGGGGGRR QQPPLAQPSA
     SPYPEAVELQ RRSLPIFQAR GQLLAQLRNL DNAVLIGETG SGKTTQIPQY LYEGGISRQG
     IIAVTQPRRV AAISLATRVS DEKRTELGKL VGYTVRFDDV TSEDTRIKFL TDGMLLREAI
     SDSLLRKYSC VILDEAHERT IHTDVLFGVV KAAQKRRKEL GKLPLKVIVM SATMDVDLFS
     QYFNGAPVLY LEGRQHPIQV FYTKQPQNDY LHAALVSVFQ IHQEAPSSQD ILVFLTGQEE
     IEAMSKTCRD IAKHLPDGCP AMLVLPLYAS LPYAQQLRVF QGAPKGYRKV IISTNIAETS
     ITITGIKYVV DTGMVKAKKY NPDSGLEVLA VQRVSKTQAW QRTGRAGRED SGICYRLYTE
     DEFEKFDKMT VPEIQRCNLA SVMLQLLAMK VPNVLTFDFM SKPSPDHIQA AIAQLDLLGA
     LEHKDDQLTL TPMGRKMAAF PLEPKFAKTI LMSPKFHCTE EILTIVSLLS VDSVLHNPPS
     RREEVQGVRK KFISSEGDHM TLLNIYRTFK NLGGNKDWCK ENFVNSKNMT LVAEVRAQLR
     DICLKMSMPI ASSRGDVESV RRCLAHSLFM STAELQPDGT YATTDTHQPV AIHPSSVLFH
     CKPACVVYTE LLYTNKCYMR DLCVIDAQWL YEAAPEYFRR KLRTARN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024